Medindia
Advertisement

New Genetic-based Epilepsy Risk Scores Developed

by Ramya Rachamanti on October 15, 2019 at 5:07 PM

New Genetic-based Epilepsy Risk Scores Developed
Genetic-based epilepsy risk scores could lay the foundation for a more individualized method of epilepsy diagnosis and treatment. This test was developed by an international team of researchers led by Cleveland Clinic.

Published in the journal Brain, the research team, led by Dennis Lal, Ph.D., a researcher in Cleveland Clinic's Genomic Medicine Institute, calculated for the first time quantitative scores that reflect overall genetic risk for epilepsy, called polygenic risk scores.
Advertisement


They showed that these scores can accurately distinguish on a cohort level between healthy patients and those with epilepsy, as well as between patients with generalized and focal epilepsies.

After the first seizure, it can be difficult for clinicians to predict which patients will go on to develop epilepsy. Development of these novel genetic risk scores could help clinicians to intervene and treat patients earlier.
Advertisement

"The fact that we can now identify people at high risk for epilepsy, and even start to distinguish between the two main types of epilepsy, based on genetic scores is really exciting," said Lal, the study's lead author. "These landmark results set the stage for an entirely new direction of epilepsy research."

Up to 40% of cases of rare neurological disorders that present with seizures can be explained by a single rare disease-causing genetic variant. Personalized therapies are in development to treat patients with many of these genes. In contrast, up until this point, the role genetic factors play in common forms of epilepsy have not guided disease management and treatment plans.

While genome-wide association studies (GWAS) have identified several common genetic variants for epilepsy, it is challenging to quantify an individual patient's genetic risk based on these variants due to small effect size (an indicator of the strength of an association).

Additionally, analyzing a single common genetic risk variant does not take into consideration the effect other variants may have on overall epilepsy risk.

To address this unmet clinical need, Dr. Lal and collaborators combined all known common genetic variants identified from several large GWAS cohorts, which included more than 12,000 people with epilepsy and 24,000 healthy controls, to calculate the polygenic risk scores in more than 8,000 people with epilepsy and 622,000 population controls.

By combining the effect sizes of thousands of common genetic variants, these scores can be used to determine an individual's risk for epilepsy.

Polygenic risk scores have been shown to have predictive and diagnostic power in a variety of medical conditions, including myocardial infarction, diabetes, and breast cancer. This study was the first to examine them in the context of epilepsy.

The research team showed that the predictive power of the polygenic risk scores developed in this study performed as well when applied to patients receiving routine clinical care.

"While additional research is necessary, we believe these findings will lay the groundwork for one day using genetic risk assessments in the clinic to diagnose common epilepsies and guide precision treatment earlier in the disease process," said Imad Najm, M.D., director of Cleveland Clinic's Epilepsy Center and co-author on the study.

Epilepsy, which affects about 1% of the U.S. population, is typically diagnosed after a patient experiences two unprovoked seizures. The two main epilepsy syndromes are generalized epilepsy (involves both cerebral hemispheres) and focal epilepsy (originates in one cerebral hemisphere), and they account for a combined 94% of incident epilepsies.

Lal led the work with first author Costin Leu, Ph.D., a computational biologist on Lal's research team at Cleveland Clinic's Genomic Medicine Institute.

The genetic data used in this study came from Cleveland Clinic's Epilepsy Center, Epi25 Collaborative (the largest epilepsy research network in the world), and additional sites around the world. The study was funded by the National Institutes of Health.

Source: Newswise
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Stroop Effect
Plant-Based Diet may Reduce the Risk of COVID-19
Lower Respiratory Tract Infections Linked to Obstructive Sleep Apnea in Children
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Epilepsy Febrile Fits / Febrile Convulsions Reye’s Syndrome Convulsions Electroencephalogram Aicardi-Goutieres Syndrome Cavernous Malformation Dravet Syndrome Absence Seizure Juvenile Myoclonic Epilepsy 

Recommended Reading
Epilepsy During Pregnancy
Seizures or epilepsy during pregnancy can be fatal for both the mother and child and needs urgent .....
Absence Seizure
Absence seizure (petit mal epilepsy) involves sudden lapse in consciousness and staring blankly into...
Aicardi-Goutieres Syndrome
Aicardi-Goutieres Syndrome is observed in infants and older children. To date, defects in 6 genes ar...
Cavernous Malformation
Cavernous malformations are malformations in blood vessels that can cause neurological disorders whe...
Convulsions
A seizure or a convulsion is a result of abnormal electrical activity in the brain. However, not all...
Dravet Syndrome
The result of a rare genetic mutation, Dravet syndrome is an unusual case of epilepsy in children....
Electroencephalogram
An electroencephalogram (EEG) detects electrical activity in the brain using electrodes attached to ...
Epilepsy
Fits or convulsions or Epilepsy is characterized by recurrent, involuntary seizures and is described...
Febrile Fits / Febrile Convulsions
High fever in kids can cause convulsions and are called febrile fits that do not include the seizure...
Juvenile Myoclonic Epilepsy
Juvenile myoclonic epilepsy is a form of generalized seizure characterized by sudden jerky movements...
Reye’s Syndrome
Reye's syndrome is a medical emergency chiefly affecting children and teenagers and is marked by the...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use